CLiC Poll #1: Chemo-Immunotherapy Firstline for CLL
Excluding patients with del(17p)/TP53 mutation, which patients should be receiving chemo-immunotherapy firstline for CLL today?
None – every patient should be receiving novel agents firstline today
Only young, fit with mutated IgVH who are eligible for curative-intent FCR
All patients except young and fit with unmutated IgHV
All patients firstline
This form was created inside of Sosido.com.